Prostate conditions affect the majority of men over 50, ranging from benign enlargement that impairs quality of life to cancer that requires careful, individualized treatment decisions. At St. George Hospital, we believe that prostate care should be thorough, nuanced, and guided by advanced diagnostics rather than reliance on a single marker.
Our prostate program begins with a comprehensive diagnostic evaluation that goes well beyond standard PSA testing. We assess prostate volume, tissue characteristics, immune status, hormonal environment, and functional impact to build a complete clinical picture before recommending treatment.
Non-cancerous prostate enlargement causing urinary obstruction, frequency, nocturia, and incomplete bladder emptying. BPH affects approximately 50% of men over 50 and up to 90% of men over 80. Our approach addresses both the mechanical obstruction and the underlying hormonal and inflammatory drivers.
From early-stage monitoring to active integrative treatment, we provide individualized protocols for prostate cancer. Our approach combines local therapies such as prostate-specific hyperthermia and photodynamic therapy with systemic support through immune modulation and insulin-potentiated therapy (IPT).
PSA (total, free, and ratio), hormonal panel (testosterone, DHT, estradiol, SHBG), inflammatory markers (CRP, IL-6), and immune profiling.
Transrectal ultrasound with volume measurement, elastography where indicated, and assessment of bladder residual volume and urinary flow dynamics.
Uroflowmetry, post-void residual measurement, IPSS symptom scoring, and quality-of-life assessment to understand the functional impact of prostate changes.
Based on the complete diagnostic picture, our physicians develop a targeted treatment plan that may combine local therapies, systemic support, and lifestyle modifications.
Controlled heat applied directly to prostate tissue to reduce BPH volume and target cancerous cells. Hyperthermia enhances immune recognition, improves local blood flow, and can be combined with other therapies for synergistic effect. This minimally invasive approach preserves surrounding tissue and function.
Light-activated compounds selectively target abnormal prostate tissue while sparing healthy cells. PDT offers a tissue-selective approach to prostate cancer treatment that minimizes damage to surrounding structures, supporting preservation of urinary and sexual function.
A systemic approach that uses insulin to enhance the uptake of low-dose therapeutic agents by cancer cells, which have significantly more insulin receptors than normal cells. IPT allows for targeted drug delivery with reduced systemic side effects compared to standard dosing.
Supporting the body's natural immune surveillance and anti-tumor response through thymus peptides, mistletoe therapy, high-dose vitamin C infusions, and targeted immunonutrition.
Optimizing the hormonal environment that influences prostate health, including testosterone-to-estradiol ratios, DHT management, and adrenal support through bioidentical and natural approaches.
Comprehensive evaluation and treatment for urinary disorders including frequency, urgency, and nocturia.
Precision diagnostics and bioidentical therapy for testosterone decline and metabolic hormone imbalances.
Our full integrative oncology program for patients seeking comprehensive cancer treatment support.
Our signature transrectal heat therapy treats benign prostate enlargement and prostate cancer while preserving urinary and sexual function.
Careful hormonal balancing addresses the androgen pathways that influence prostate growth, inflammation, and cancer risk.
Platelet-rich plasma supports tissue healing and reduces inflammation in the prostate and surrounding pelvic structures.
Immune support therapies strengthen natural defenses against prostate cancer and reduce chronic prostatic inflammation.
Contact our team for a confidential consultation. We will review your history and recommend the most appropriate diagnostic and treatment pathway.
